Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126101611 | 12610161 | 1 | I | 20120106 | 0 | 20160729 | 20160729 | DIR | 15.00 | YR | F | N | 76.00000 | LBS | 20160728 | N | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126101611 | 12610161 | 1 | PS | ATIVAN | LORAZEPAM | 1 | Oral | Y | D | 0 | |||||||||
126101611 | 12610161 | 3 | C | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | 0 | ||||||||||||
126101611 | 12610161 | 5 | C | MELATONIN | MELATONIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126101611 | 12610161 | 1 | Anxiety |
126101611 | 12610161 | 1 | Panic attack |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126101611 | 12610161 | HO |
126101611 | 12610161 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126101611 | 12610161 | Anger | |
126101611 | 12610161 | Anxiety | |
126101611 | 12610161 | Dehydration | |
126101611 | 12610161 | Disorientation |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
126101611 | 12610161 | FGN |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126101611 | 12610161 | 1 | 20120106 | 20120106 | 0 |